Neoplasms

"Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.

Descriptor ID	D009369
MeSH Number(s)	C04
Concept/Terms	Neoplasms Neoplasms Neoplasia Neoplasias Neoplasm Tumors Tumor Cancer Cancer Cancers Malignant Neoplasms Malignant Neoplasm Neoplasm, Malignant Neoplasms, Malignant Malignancy Malignancies Benign Neoplasms Benign Neoplasms Neoplasms, Benign Benign Neoplasm Neoplasm, Benign

Below are MeSH descriptors whose meaning is more general than "Neoplasms".

Diseases [C]
Neoplasms [C04]

Below are MeSH descriptors whose meaning is more specific than "Neoplasms".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Neoplasms" by people in this website by year, and whether "Neoplasms" was a major or minor topic of these publications.

Bar chart showing 1026 publications over 31 distinct years, with a maximum of 65 publications in 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	1	3	4
1996	4	3	7
1997	1	1	2
1998	3	1	4
1999	1	4	5
2000	4	4	8
2001	8	4	12
2002	7	7	14
2003	15	3	18
2004	19	6	25
2005	15	5	20
2006	18	7	25
2007	29	8	37
2008	35	12	47
2009	26	6	32
2010	35	12	47
2011	27	7	34
2012	30	11	41
2013	45	6	51
2014	40	9	49
2015	31	4	35
2016	39	9	48
2017	52	8	60
2018	38	11	49
2019	50	7	57
2020	58	7	65
2021	48	5	53
2022	57	0	57
2023	55	2	57
2024	36	17	53
2025	6	4	10

Below are the most recent publications written about "Neoplasms" by people in Profiles.

Gutmann DH, Boehm JS, Karlsson EK, Padron E, Seshadri M, Wallis D, Snyder JC. Precision preclinical modeling to advance cancer treatment. J Natl Cancer Inst. 2025 Apr 01; 117(4):586-594.

View in: PubMed
Gerber WK, Xie Y, Patel SA. Expanding the Therapeutic Reach of Chimeric Antigen Receptor T-Cells and Bispecific T-Cell Engagers Across Solid Tumors. JCO Precis Oncol. 2025 Mar; 9:e2400753.

View in: PubMed
Nguyen LHD, Nguyen THH, Le VH, Bui VQ, Nguyen LH, Pham NH, Phan TH, Nguyen HT, Tran VS, Bui CV, Vo VK, Nguyen PTN, Dang HHP, Pham VD, Cao VT, Phan NM, Tieu BL, Nguyen GTH, Vo DH, Tran TH, Nguyen TD, Nguyen VTC, Nguyen TH, Tran VU, Le MP, Tran TMT, Nguyen Nguyen M, Van TTV, Nguyen AN, Nguyen TT, Doan NNT, Nguyen HT, Doan PL, Huynh LAK, Nguyen TA, Nguyen HTP, Lu YT, Cao CTT, Nguyen VT, Le Quyen Le T, Luong TL, Doan TKP, Dao TT, Phan CD, Nguyen TX, Pham NT, Nguyen BT, Pham TTT, Le HL, Truong CT, Jasmine TX, Le MC, Phan VB, Truong QB, Tran THL, Huynh MT, Tran TQ, Nguyen ST, Tran V, Tran VK, Nguyen Nguyen H, Nguyen DS, Van Phan T, Do TT, Truong DK, Tang HS, Giang H, Nguyen HN, Phan MD, Tran LS. Prospective validation study: a non-invasive circulating tumor DNA-based assay for simultaneous early detection of multiple cancers in asymptomatic adults. BMC Med. 2025 Feb 14; 23(1):90.

View in: PubMed
Eche-Ugwu IJ, Aronowitz T, Broden EG, Merz A, Vernadakis A, Bullock K, Wolfe J, Feraco AM. Uncovering Structurally Differential Care: Pediatric Oncology Nurses' Perspectives Caring for African American Families. J Pain Symptom Manage. 2025 May; 69(5):455-464.

View in: PubMed
Lee N, Kim D. Adapt or Perish: Efficient Selenocysteine Insertion Is Critical for Metastasizing Cancer Cells. Cancer Res. 2025 Feb 01; 85(3):410-412.

View in: PubMed
Messina MS, Torrente L, Pezacki AT, Humpel HI, Li EL, Miller SG, Verdejo-Torres O, Padilla-Benavides T, Brady DC, Killilea DW, Killilea AN, Ralle M, Ward NP, Ohata J, DeNicola GM, Chang CJ. A histochemical approach to activity-based copper sensing reveals cuproplasia-dependent vulnerabilities in cancer. Proc Natl Acad Sci U S A. 2025 Jan 21; 122(3):e2412816122.

View in: PubMed
Perera L, Brown SM, Silver BB, Tokar EJ, Sinha BK. Ferroptosis Inducers Erastin and RSL3 Enhance Adriamycin and Topotecan Sensitivity in ABCB1/ABCG2-Expressing Tumor Cells. Int J Mol Sci. 2025 Jan 14; 26(2).

View in: PubMed
Cruz FM, Orellano LAA, Chan A, Rock KL. Alternate MHC I Antigen Presentation Pathways Allow CD8+ T-cell Recognition and Killing of Cancer Cells in the Absence of ?2M or TAP. Cancer Immunol Res. 2025 Jan 09; 13(1):98-108.

View in: PubMed
Malode A, Makwana B, Patel V, Khadke S, Parikh A, Bagga A, Dani S, Ganatra S. Cardiotoxicity and peri-operative considerations in immune checkpoint inhibitor and chimeric antigen receptor T-cell therapy: a narrative review. Anaesthesia. 2025 Feb; 80 Suppl 2:25-37.

View in: PubMed
Nguyen THH, Vu GH, Nguyen TT, Nguyen TA, Tran VU, Vu LT, Nguyen GTH, Nguyen ND, Tran TH, Nguyen VTC, Nguyen TD, Nguyen TH, Vo DH, Van TTV, Do TT, Le MP, Huynh LAK, Nguyen DS, Tang HS, Nguyen HN, Phan MD, Giang H, Tu LN, Tran LS. Combination of Hotspot Mutations With Methylation and Fragmentomic Profiles to Enhance Multi-Cancer Early Detection. Cancer Med. 2025 Jan; 14(1):e70575.

View in: PubMed

People

Explore

Similar Concepts

Top Journals